7-溴二氢吲哚 | 62813-85-8

• 物质功能分类: 医药中间体 - 杂环化合物 - 吲哚类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 7-溴二氢吲哚
• 中文别名: 7-溴吲哚啉
• 英文名称: 7-bromoindoline
• 英文别名: 7-bromo-2,3-dihydro-1H-indole
• CAS: 62813-85-8
• 化学式: C₈H₈BrN
• 分子量: 198.062
• InChiKey: SCMZOGDYYXXXCP-UHFFFAOYSA-N

物化性质

• 沸点：
  279.4±29.0 °C(Predicted)
• 密度：
  1.514±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  存储条件：2-8°C，密封保存，干燥环境且避免光照。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 7-Bromo-2,3-dihydro-1H-indole
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 7-Bromo-2,3-dihydro-1H-indole
CAS number: 62813-85-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H8BrN
Molecular weight: 198.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  7-溴二氢吲哚 在 palladium on activated charcoal 正丁基锂 、 1,1,2,2-四氟-1,2-二溴乙烷 、 硫酸 、 氢气 、 magnesium 作用下， 反应 9.25h， 生成 去氢石蒜碱酮
  参考文献：
  名称：

  An Oxazoline-Mediated Synthesis of the Pyrrolophenanthridine Alkaloids and Some Novel Derivatives

  摘要：

  An unsymmetrical biaryl coupling between the Grignard of N-benzyl-7-bromoindoline 25 and the appropriately substituted (o-methoxyaryl)oxazoline 15 leads to an intermediate biaryl which can be elaborated in one step to the 1H-pyrrolo[3,2,1-de]phenanthridine ring system. This simple two-step sequence provides general access to the pyrrolophenanthridine alkaloids 2-6.

  DOI：

  10.1021/jo951474x
• 作为产物：
  描述：

  N-乙酰基吲哚啉 在 sodium hydroxide 、 copper(ll) bromide 、 thallium(III) trifluoroacetate 作用下， 以 甲醇 、 水 为溶剂， 反应 6.5h， 生成 7-溴二氢吲哚
  参考文献：
  名称：

  Somei, Masanori; Saida, Yoshihiro; Funamoto, Tetsuo, Chemical and pharmaceutical bulletin, 1987, vol. 35, # 8, p. 3146 - 3154

  摘要：

  DOI：

文献信息

• A Pd-catalyzed, boron ester-mediated, reductive cross-coupling of two aryl halides to synthesize tricyclic biaryls
  作者：Zhilong Chen、Xiaodong Wang

  DOI：10.1039/c7ob01237c

  日期：——

  Tricyclic biaryls are important scaffold structures in many natural products and lead compounds in drug discovery. The formation of a biaryl unit is often the key step for the synthesis of tricyclic biaryls. Despite significant progress toward the synthesis of biaryl compounds in recent years, the direct cross-coupling of two different aryl halides is still challenging and robust methods are lacking

  三环联芳基在许多天然产物中是重要的支架结构，在药物发现中是先导化合物。联芳基单元的形成通常是合成三环联芳基的关键步骤。尽管近年来在合成联芳基化合物方面取得了重大进展，但是两种不同的芳基卤化物的直接交叉偶联仍然具有挑战性，并且缺乏可靠的方法。在本文中，我们报道了在钯催化剂和硼酸酯存在下两种不同的芳基卤化物的直接交叉偶联，这为合成三环联芳基提供了一种新的有用的互补方法。
• Covalent Organic Frameworks toward Diverse Photocatalytic Aerobic Oxidations
  作者：Shuyang Liu、Miao Tian、Xiubin Bu、Hua Tian、Xiaobo Yang

  DOI：10.1002/chem.202100398

  日期：2021.5.17

  two‐dimensional covalent organic frameworks (2D‐COFs) have become promising heterogenous photocatalysts in visible‐light‐driven organic transformations. Herein, a visible‐light‐driven selective aerobic oxidation of various small organic molecules by using 2D‐COFs as the photocatalyst was developed. In this protocol, due to the remarkable photocatalytic capability of hydrazone‐based 2D‐COF‐1 on molecular

  在可见光驱动的有机转化中，光活性二维共价有机骨架（2D-COF）已成为有前途的多相光催化剂。在此，通过使用二维COFs作为光催化剂，开发了可见光驱动的各种有机小分子的选择性好氧氧化。在该方案中，由于2D-COF-1对分子氧活化具有非凡的光催化能力，因此在非常温和的条件下获得了高效，优异的官能团耐受性的各种酰胺，喹诺酮，杂环化合物和亚砜。反应条件。此外，得益于多相光催化的固有优势，突出的可持续性和易于光催化的可回收性，在按比例放大反应中，有选择地轻松获得了一种药物分子（莫达非尼）和一种氧化芥子气模拟物（2-氯乙基乙基亚砜）。使用自由基猝灭实验和原位ESR光谱进行了机理研究，证实了2D-COF-1在光催化循环中的作用。
• Ni‐Catalyzed [4+3+2] Cycloaddition of Ethyl Cyclopropylideneacetate and Dienynes: Scope and Mechanistic Insights
  作者：Ryu Yamasaki、Masato Ohashi、Kyotaro Maeda、Takuya Kitamura、Minami Nakagawa、Korehito Kato、Tetsushi Fujita、Ryohei Kamura、Kazuto Kinoshita、Hyuma Masu、Isao Azumaya、Sensuke Ogoshi、Shinichi Saito

  DOI：10.1002/chem.201204087

  日期：2013.3.4

  A detailed study of the Ni‐catalyzed [4+3+2] cycloaddition reaction between ethyl cyclopropylideneacetate and dienynes has been conducted, resulting in the development of a new method for the synthesis of compounds containing nine‐membered rings. We studied the reactivity of various dienynes, together with their substituent and conformational effects. The mechanism of the reaction was probed by examining

  进行了Ni催化的[4 + 3 + 2]环丙基亚乙基乙酸乙酯与二烯酮之间环加成反应的详细研究，从而开发了一种新的合成含九元环化合物的新方法。我们研究了各种二烯的反应性，以及它们的取代基和构象效应。通过检查Ni配合物和二烯的化学计量反应来探究该反应的机理。
• Synthesis of phenanthridine skeletal Amaryllidaceae alkaloids
  作者：Tai-Ting Fan-Chiang、Hung-Kai Wang、Jen-Chieh Hsieh

  DOI：10.1016/j.tet.2016.07.065

  日期：2016.9

  Strategies for the synthesis of Amaryllidaceae alkaloids, including crinasiadine, trisphaeridine, bicolorine, N-methylcrinasiadine, 5,6-dihydrobicolorine, galanthindole, lycosinine A and lycosinine B were reported. Investigation of optionally synthetic routes to approach bicolorine, 5,6-dihydrobicolorine, trisphaeridine and N-methylcrinasiadine were demonstrated as well. In addition, three structurally

  报道了合成金缕梅科生物碱的策略，包括克林达西定，三叶啶，双色氨酸，N-甲基肉桂酸，5,6-二氢双色氨酸，加兰地吲哚，赖氨酸A和赖氨酸B。还证明了对接近双色氨酸，5，6-二氢双色氨酸，三叶啶和N-甲基肉桂酸的任选合成途径的研究。此外，以铃木偶合反应为关键步骤，简明地制备了三种结构相关的生物碱加兰索尔，溶血素A和溶血素B。
• N-substituted spiropiperidine compounds as ligands for ORL-1 receptor
  申请人：——

  公开号：US20030158219A1

  公开（公告）日：2003-08-21

  A compound of the formula: 1 or a pharmaceutically acceptable salt, ester or ether thereof, wherein R 1 through R 12 are independently hydrogen or the like; X 1 and X 2 are independently CH 2 or the like; R 13 is hydrogen or the like; or R 12 and R 13 taken together with three ring atoms of the quinoline ring separating said substituents form a heterocyclic ring; R 14 and R 15 are hydrogen or the like or these groups taken together form oxo; and the dotted line represents a single or double bond. These compounds are ligands for ORL-1 receptor and especially are antagonists for said receptor.

  该化合物的结构式为：1或其药用可接受的盐、酯或醚，其中R1到R12独立地是氢或类似物；X1和X2独立地是CH2或类似物；R13是氢或类似物；或者R12和R13与喹啉环的三个环原子一起形成杂环环；R14和R15是氢或类似物，或这些基团一起形成氧化物；虚线代表单键或双键。这些化合物是ORL-1受体的配体，特别是该受体的拮抗剂。